Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2034, some of which include options to extend the lease for up to seven years. For the six months ended December 2022 and December 2021, we recorded approximately $6.3 million and $5.7 million, respectively, of operating leases expense. Our short-term leases are immaterial.

As of December 2022 and June 2022, the components of leases are as follows (in millions):


	December		June
	2022		2022
Operating lease right-of-use assets	$	53.0	$	61.2
Operating lease liabilities	$	7.8	$	7.6
Operating lease liabilities, long-term		45.3		51.5
Total operating lease liabilities	$	53.1	$	59.1

Supplemental cash flow information related to leases, including from acquisitions, is as follows (in millions):


	Six Months Ended
	December
	2022		2021
Cash paid for operating leases included in operating cash flows	$	6.2	$	5.4
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets	$	6.7	$	17.6

As of December 2022, the weighted average remaining lease term is 7.5 years, and the weighted average discount rate is 5.1%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):


	Operating
	Lease
Fiscal Year	Payments
Remainder of 2023	$	2.5
2024		11.2
2025		9.8
2026		8.3
2027		7.3
Thereafter		26.0
Total future minimum operating lease payments		65.1
Less: interest		(12.0	)
Total lease liabilities	$	53.1